avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Hic1
|
ENSMUSG00000043099.4 | hypermethylated in cancer 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Hic1 | mm10_v2_chr11_-_75169519_75169519 | -0.20 | 2.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_-_83337440 | 5.55 |
ENSMUST00000126617.1
|
Slc41a2
|
solute carrier family 41, member 2 |
chr14_+_59201418 | 4.94 |
ENSMUST00000140136.2
ENSMUST00000142326.1 |
Rcbtb1
|
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1 |
chr4_-_46991842 | 4.90 |
ENSMUST00000107749.2
|
Gabbr2
|
gamma-aminobutyric acid (GABA) B receptor, 2 |
chr8_-_84800024 | 4.70 |
ENSMUST00000126806.1
ENSMUST00000076715.6 |
Nfix
|
nuclear factor I/X |
chr6_+_17463826 | 3.98 |
ENSMUST00000140070.1
|
Met
|
met proto-oncogene |
chr10_-_83337845 | 3.87 |
ENSMUST00000039956.5
|
Slc41a2
|
solute carrier family 41, member 2 |
chr1_+_72824482 | 3.85 |
ENSMUST00000047328.4
|
Igfbp2
|
insulin-like growth factor binding protein 2 |
chr13_+_37826904 | 3.74 |
ENSMUST00000149745.1
|
Rreb1
|
ras responsive element binding protein 1 |
chr8_-_84800344 | 3.39 |
ENSMUST00000099070.3
|
Nfix
|
nuclear factor I/X |
chr8_-_25038875 | 3.18 |
ENSMUST00000084031.4
|
Htra4
|
HtrA serine peptidase 4 |
chr3_-_131303144 | 3.14 |
ENSMUST00000106337.2
|
Cyp2u1
|
cytochrome P450, family 2, subfamily u, polypeptide 1 |
chr3_-_18243289 | 2.87 |
ENSMUST00000035625.6
|
Cyp7b1
|
cytochrome P450, family 7, subfamily b, polypeptide 1 |
chr3_+_63295815 | 2.78 |
ENSMUST00000029400.1
|
Mme
|
membrane metallo endopeptidase |
chr2_-_65239039 | 2.78 |
ENSMUST00000155916.1
|
Cobll1
|
Cobl-like 1 |
chr11_+_94211431 | 2.71 |
ENSMUST00000041589.5
|
Tob1
|
transducer of ErbB-2.1 |
chr3_-_148989316 | 2.69 |
ENSMUST00000098518.2
|
Lphn2
|
latrophilin 2 |
chr4_+_141368116 | 2.67 |
ENSMUST00000006380.4
|
Fam131c
|
family with sequence similarity 131, member C |
chr10_-_88503952 | 2.62 |
ENSMUST00000020253.8
|
Chpt1
|
choline phosphotransferase 1 |
chr4_-_149307506 | 2.59 |
ENSMUST00000055647.8
ENSMUST00000030806.5 ENSMUST00000060537.6 |
Kif1b
|
kinesin family member 1B |
chr8_+_127064107 | 2.58 |
ENSMUST00000162536.1
ENSMUST00000026921.6 ENSMUST00000162665.1 ENSMUST00000160766.1 ENSMUST00000162602.1 ENSMUST00000162531.1 ENSMUST00000160581.1 ENSMUST00000161355.1 ENSMUST00000159537.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr7_+_65862029 | 2.57 |
ENSMUST00000055576.5
ENSMUST00000098391.4 |
Pcsk6
|
proprotein convertase subtilisin/kexin type 6 |
chr9_-_42264200 | 2.56 |
ENSMUST00000169609.1
|
Sc5d
|
sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) |
chr2_-_65238573 | 2.53 |
ENSMUST00000090896.3
ENSMUST00000155082.1 |
Cobll1
|
Cobl-like 1 |
chr2_-_65238721 | 2.50 |
ENSMUST00000112431.1
|
Cobll1
|
Cobl-like 1 |
chr10_+_19934472 | 2.50 |
ENSMUST00000095806.3
ENSMUST00000120259.1 |
Map3k5
|
mitogen-activated protein kinase kinase kinase 5 |
chr16_+_31663841 | 2.46 |
ENSMUST00000115201.1
|
Dlg1
|
discs, large homolog 1 (Drosophila) |
chr6_+_17463927 | 2.44 |
ENSMUST00000115442.1
|
Met
|
met proto-oncogene |
chr18_-_61911783 | 2.43 |
ENSMUST00000049378.8
ENSMUST00000166783.1 |
Ablim3
|
actin binding LIM protein family, member 3 |
chr16_+_26581704 | 2.40 |
ENSMUST00000096129.2
ENSMUST00000166294.2 ENSMUST00000174202.1 ENSMUST00000023156.6 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr1_+_182763961 | 2.35 |
ENSMUST00000153348.1
|
Susd4
|
sushi domain containing 4 |
chrX_+_71364901 | 2.35 |
ENSMUST00000132837.1
|
Mtmr1
|
myotubularin related protein 1 |
chr19_+_57611020 | 2.33 |
ENSMUST00000077282.5
|
Atrnl1
|
attractin like 1 |
chr2_+_155382186 | 2.33 |
ENSMUST00000134218.1
|
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr11_-_70700105 | 2.33 |
ENSMUST00000108543.3
ENSMUST00000108542.1 ENSMUST00000108541.2 ENSMUST00000126114.2 ENSMUST00000073625.1 |
Inca1
|
inhibitor of CDK, cyclin A1 interacting protein 1 |
chr16_-_46010212 | 2.30 |
ENSMUST00000130481.1
|
Plcxd2
|
phosphatidylinositol-specific phospholipase C, X domain containing 2 |
chr10_-_81430966 | 2.23 |
ENSMUST00000117966.1
|
Nfic
|
nuclear factor I/C |
chr7_-_114562945 | 2.22 |
ENSMUST00000119712.1
ENSMUST00000032908.8 |
Cyp2r1
|
cytochrome P450, family 2, subfamily r, polypeptide 1 |
chr18_+_64340225 | 2.22 |
ENSMUST00000175965.2
ENSMUST00000115145.3 |
Onecut2
|
one cut domain, family member 2 |
chr2_-_36105271 | 2.21 |
ENSMUST00000112960.1
ENSMUST00000112967.5 ENSMUST00000112963.1 |
Lhx6
|
LIM homeobox protein 6 |
chr9_+_121642716 | 2.20 |
ENSMUST00000035115.4
|
Vipr1
|
vasoactive intestinal peptide receptor 1 |
chr5_+_144768536 | 2.18 |
ENSMUST00000128550.1
|
Trrap
|
transformation/transcription domain-associated protein |
chr9_-_42264226 | 2.17 |
ENSMUST00000052725.7
|
Sc5d
|
sterol-C5-desaturase (fungal ERG3, delta-5-desaturase) homolog (S. cerevisae) |
chr11_-_106613370 | 2.16 |
ENSMUST00000128933.1
|
Tex2
|
testis expressed gene 2 |
chr10_-_88504073 | 2.16 |
ENSMUST00000117440.1
|
Chpt1
|
choline phosphotransferase 1 |
chr13_-_69611421 | 2.14 |
ENSMUST00000091514.5
|
Srd5a1
|
steroid 5 alpha-reductase 1 |
chr5_-_53213447 | 2.09 |
ENSMUST00000031090.6
|
Sel1l3
|
sel-1 suppressor of lin-12-like 3 (C. elegans) |
chr4_-_105109829 | 2.05 |
ENSMUST00000030243.7
|
Prkaa2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit |
chr2_-_65238625 | 2.04 |
ENSMUST00000112429.2
ENSMUST00000102726.1 ENSMUST00000112430.1 |
Cobll1
|
Cobl-like 1 |
chr2_+_155381808 | 2.04 |
ENSMUST00000043237.7
ENSMUST00000174685.1 |
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr19_-_29047847 | 2.03 |
ENSMUST00000025696.4
|
Ak3
|
adenylate kinase 3 |
chr17_-_32788284 | 2.01 |
ENSMUST00000159086.2
|
Zfp871
|
zinc finger protein 871 |
chr13_-_64129305 | 1.91 |
ENSMUST00000099441.4
|
Slc35d2
|
solute carrier family 35, member D2 |
chr2_-_132145057 | 1.90 |
ENSMUST00000028815.8
|
Slc23a2
|
solute carrier family 23 (nucleobase transporters), member 2 |
chr7_+_113207465 | 1.88 |
ENSMUST00000047321.7
|
Arntl
|
aryl hydrocarbon receptor nuclear translocator-like |
chr11_-_87987528 | 1.87 |
ENSMUST00000020775.2
|
Dynll2
|
dynein light chain LC8-type 2 |
chr2_-_166155272 | 1.87 |
ENSMUST00000088086.3
|
Sulf2
|
sulfatase 2 |
chr2_-_5714490 | 1.86 |
ENSMUST00000044009.7
|
Camk1d
|
calcium/calmodulin-dependent protein kinase ID |
chr11_+_70700606 | 1.85 |
ENSMUST00000137119.2
|
Kif1c
|
kinesin family member 1C |
chr10_+_11343387 | 1.85 |
ENSMUST00000069106.4
|
Epm2a
|
epilepsy, progressive myoclonic epilepsy, type 2 gene alpha |
chr15_-_76232554 | 1.84 |
ENSMUST00000166428.1
|
Plec
|
plectin |
chr8_+_85492568 | 1.84 |
ENSMUST00000034136.5
|
Gpt2
|
glutamic pyruvate transaminase (alanine aminotransferase) 2 |
chr1_-_52727457 | 1.84 |
ENSMUST00000156876.1
ENSMUST00000087701.3 |
Mfsd6
|
major facilitator superfamily domain containing 6 |
chr5_-_62765618 | 1.82 |
ENSMUST00000159470.1
|
Arap2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr6_+_4601124 | 1.81 |
ENSMUST00000181734.1
ENSMUST00000141359.1 |
Casd1
|
CAS1 domain containing 1 |
chr16_+_38902305 | 1.80 |
ENSMUST00000023478.7
|
Igsf11
|
immunoglobulin superfamily, member 11 |
chr5_+_9100681 | 1.76 |
ENSMUST00000115365.1
|
Tmem243
|
transmembrane protein 243, mitochondrial |
chr12_+_19606929 | 1.75 |
ENSMUST00000105167.1
|
Gm9257
|
predicted gene 9257 |
chr14_-_45529964 | 1.75 |
ENSMUST00000150660.1
|
Fermt2
|
fermitin family homolog 2 (Drosophila) |
chr5_-_34187670 | 1.74 |
ENSMUST00000042701.6
ENSMUST00000119171.1 |
Mxd4
|
Max dimerization protein 4 |
chr2_+_25054355 | 1.73 |
ENSMUST00000100334.4
ENSMUST00000152122.1 ENSMUST00000116574.3 ENSMUST00000006646.8 |
Nsmf
|
NMDA receptor synaptonuclear signaling and neuronal migration factor |
chr9_-_29412204 | 1.72 |
ENSMUST00000115237.1
|
Ntm
|
neurotrimin |
chr19_+_38481057 | 1.72 |
ENSMUST00000182481.1
|
Plce1
|
phospholipase C, epsilon 1 |
chr7_-_35215248 | 1.72 |
ENSMUST00000118444.1
ENSMUST00000122409.1 |
Lrp3
|
low density lipoprotein receptor-related protein 3 |
chr8_+_95352258 | 1.71 |
ENSMUST00000034243.5
|
Mmp15
|
matrix metallopeptidase 15 |
chr3_+_54755574 | 1.69 |
ENSMUST00000029371.2
|
Smad9
|
SMAD family member 9 |
chr5_-_62766153 | 1.69 |
ENSMUST00000076623.4
|
Arap2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2 |
chr6_+_138140298 | 1.68 |
ENSMUST00000008684.4
|
Mgst1
|
microsomal glutathione S-transferase 1 |
chr7_+_87246649 | 1.67 |
ENSMUST00000068829.5
ENSMUST00000032781.7 |
Nox4
|
NADPH oxidase 4 |
chr15_-_55906722 | 1.67 |
ENSMUST00000110200.2
|
Sntb1
|
syntrophin, basic 1 |
chr10_+_7589788 | 1.67 |
ENSMUST00000134346.1
ENSMUST00000019931.5 |
Lrp11
|
low density lipoprotein receptor-related protein 11 |
chr1_+_93235836 | 1.67 |
ENSMUST00000062202.7
|
Sned1
|
sushi, nidogen and EGF-like domains 1 |
chr17_-_32284715 | 1.67 |
ENSMUST00000127893.1
|
Brd4
|
bromodomain containing 4 |
chr9_-_54068346 | 1.66 |
ENSMUST00000098760.3
|
Tnfaip8l3
|
tumor necrosis factor, alpha-induced protein 8-like 3 |
chr14_-_55745647 | 1.63 |
ENSMUST00000002403.8
|
Dhrs1
|
dehydrogenase/reductase (SDR family) member 1 |
chr2_+_30364262 | 1.63 |
ENSMUST00000142801.1
ENSMUST00000100214.3 |
Fam73b
|
family with sequence similarity 73, member B |
chr19_-_28963863 | 1.62 |
ENSMUST00000161813.1
|
4430402I18Rik
|
RIKEN cDNA 4430402I18 gene |
chr17_+_13760502 | 1.62 |
ENSMUST00000139347.1
ENSMUST00000156591.1 ENSMUST00000170827.2 ENSMUST00000139666.1 ENSMUST00000137784.1 ENSMUST00000137708.1 ENSMUST00000150848.1 |
Mllt4
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 4 |
chr6_-_119544282 | 1.62 |
ENSMUST00000119369.1
ENSMUST00000178696.1 |
Wnt5b
|
wingless-related MMTV integration site 5B |
chr11_+_70700473 | 1.61 |
ENSMUST00000152618.2
ENSMUST00000102554.1 ENSMUST00000094499.4 ENSMUST00000072187.5 |
Kif1c
|
kinesin family member 1C |
chr10_+_7589885 | 1.61 |
ENSMUST00000130590.1
ENSMUST00000135907.1 |
Lrp11
|
low density lipoprotein receptor-related protein 11 |
chr7_+_44590886 | 1.61 |
ENSMUST00000107906.3
|
Kcnc3
|
potassium voltage gated channel, Shaw-related subfamily, member 3 |
chr12_+_103532435 | 1.60 |
ENSMUST00000021631.5
|
Ppp4r4
|
protein phosphatase 4, regulatory subunit 4 |
chr12_-_75735729 | 1.60 |
ENSMUST00000021450.4
|
Sgpp1
|
sphingosine-1-phosphate phosphatase 1 |
chr9_-_98955302 | 1.60 |
ENSMUST00000181706.1
|
Foxl2os
|
forkhead box L2 opposite strand transcript |
chr4_-_81442756 | 1.59 |
ENSMUST00000107262.1
ENSMUST00000102830.3 |
Mpdz
|
multiple PDZ domain protein |
chr6_+_88724462 | 1.58 |
ENSMUST00000113582.1
|
Mgll
|
monoglyceride lipase |
chr6_+_17463749 | 1.58 |
ENSMUST00000115443.1
|
Met
|
met proto-oncogene |
chr12_+_111166485 | 1.57 |
ENSMUST00000139162.1
|
Traf3
|
TNF receptor-associated factor 3 |
chr9_+_72662473 | 1.55 |
ENSMUST00000184450.1
ENSMUST00000183375.1 |
Nedd4
|
neural precursor cell expressed, developmentally down-regulated 4 |
chr16_-_4420416 | 1.54 |
ENSMUST00000120080.1
|
Adcy9
|
adenylate cyclase 9 |
chr2_+_25054396 | 1.54 |
ENSMUST00000102931.4
ENSMUST00000074422.7 ENSMUST00000132172.1 ENSMUST00000114388.1 ENSMUST00000114386.1 |
Nsmf
|
NMDA receptor synaptonuclear signaling and neuronal migration factor |
chr16_+_44173239 | 1.54 |
ENSMUST00000119746.1
|
Gm608
|
predicted gene 608 |
chr2_+_30364227 | 1.53 |
ENSMUST00000077977.7
ENSMUST00000140075.2 |
Fam73b
|
family with sequence similarity 73, member B |
chr17_-_31636631 | 1.53 |
ENSMUST00000135425.1
ENSMUST00000151718.1 ENSMUST00000155814.1 |
Cbs
|
cystathionine beta-synthase |
chr1_-_55363462 | 1.53 |
ENSMUST00000159398.1
|
Boll
|
bol, boule-like (Drosophila) |
chr17_-_79020816 | 1.53 |
ENSMUST00000168887.1
ENSMUST00000119284.1 |
Prkd3
|
protein kinase D3 |
chr2_+_127270694 | 1.52 |
ENSMUST00000125049.1
ENSMUST00000110374.1 |
Stard7
|
START domain containing 7 |
chr3_-_67515487 | 1.52 |
ENSMUST00000178314.1
ENSMUST00000054825.4 |
Rarres1
|
retinoic acid receptor responder (tazarotene induced) 1 |
chr10_-_78352469 | 1.51 |
ENSMUST00000138035.1
|
Agpat3
|
1-acylglycerol-3-phosphate O-acyltransferase 3 |
chr11_-_121388186 | 1.50 |
ENSMUST00000106107.2
|
Rab40b
|
Rab40b, member RAS oncogene family |
chr4_+_83525540 | 1.49 |
ENSMUST00000053414.6
ENSMUST00000126429.1 |
Ccdc171
|
coiled-coil domain containing 171 |
chr6_+_116264186 | 1.48 |
ENSMUST00000036503.7
ENSMUST00000112900.3 |
Zfand4
|
zinc finger, AN1-type domain 4 |
chr14_-_65953728 | 1.48 |
ENSMUST00000042046.3
|
Scara3
|
scavenger receptor class A, member 3 |
chrX_+_71364745 | 1.45 |
ENSMUST00000114601.1
ENSMUST00000146213.1 ENSMUST00000015358.1 |
Mtmr1
|
myotubularin related protein 1 |
chr11_+_108920800 | 1.45 |
ENSMUST00000140821.1
|
Axin2
|
axin2 |
chr19_+_36554661 | 1.43 |
ENSMUST00000169036.2
ENSMUST00000047247.5 |
Hectd2
|
HECT domain containing 2 |
chr17_+_26715644 | 1.43 |
ENSMUST00000062519.7
ENSMUST00000144221.1 ENSMUST00000142539.1 ENSMUST00000151681.1 |
Crebrf
|
CREB3 regulatory factor |
chr10_-_68278713 | 1.43 |
ENSMUST00000020106.7
|
Arid5b
|
AT rich interactive domain 5B (MRF1-like) |
chr9_+_122117258 | 1.43 |
ENSMUST00000146832.1
ENSMUST00000139181.1 |
Snrk
|
SNF related kinase |
chr2_+_76675265 | 1.43 |
ENSMUST00000111920.1
|
Plekha3
|
pleckstrin homology domain-containing, family A (phosphoinositide binding specific) member 3 |
chr6_+_87981683 | 1.42 |
ENSMUST00000143871.1
ENSMUST00000153372.1 |
Gm5577
|
predicted gene 5577 |
chr2_-_73386396 | 1.42 |
ENSMUST00000112044.1
ENSMUST00000112043.1 ENSMUST00000076463.5 |
Gpr155
|
G protein-coupled receptor 155 |
chr1_+_131962941 | 1.42 |
ENSMUST00000177943.1
|
Slc45a3
|
solute carrier family 45, member 3 |
chr8_+_76899772 | 1.42 |
ENSMUST00000109913.2
|
Nr3c2
|
nuclear receptor subfamily 3, group C, member 2 |
chr2_-_65239092 | 1.40 |
ENSMUST00000156643.1
|
Cobll1
|
Cobl-like 1 |
chr1_-_132139605 | 1.39 |
ENSMUST00000112362.2
|
Cdk18
|
cyclin-dependent kinase 18 |
chr15_+_87625214 | 1.39 |
ENSMUST00000068088.6
|
Fam19a5
|
family with sequence similarity 19, member A5 |
chr15_-_31367527 | 1.39 |
ENSMUST00000076942.4
ENSMUST00000123325.1 ENSMUST00000110410.2 |
Ankrd33b
|
ankyrin repeat domain 33B |
chr19_+_44989073 | 1.39 |
ENSMUST00000026225.8
|
Sema4g
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4G |
chr8_-_123158229 | 1.38 |
ENSMUST00000137998.1
|
Sult5a1
|
sulfotransferase family 5A, member 1 |
chr9_-_66975387 | 1.37 |
ENSMUST00000034929.6
|
Lactb
|
lactamase, beta |
chr4_-_57143437 | 1.37 |
ENSMUST00000095076.3
ENSMUST00000030142.3 |
Epb4.1l4b
|
erythrocyte protein band 4.1-like 4b |
chr11_-_23633621 | 1.37 |
ENSMUST00000180260.1
ENSMUST00000141353.1 ENSMUST00000131612.1 ENSMUST00000109532.2 |
0610010F05Rik
|
RIKEN cDNA 0610010F05 gene |
chr16_-_4213404 | 1.37 |
ENSMUST00000023165.6
|
Crebbp
|
CREB binding protein |
chr8_-_94012120 | 1.37 |
ENSMUST00000143265.1
|
Amfr
|
autocrine motility factor receptor |
chr13_+_104109752 | 1.36 |
ENSMUST00000160322.1
ENSMUST00000159574.1 |
Sgtb
|
small glutamine-rich tetratricopeptide repeat (TPR)-containing, beta |
chr2_+_4717825 | 1.36 |
ENSMUST00000184139.1
ENSMUST00000115022.1 |
Bend7
|
BEN domain containing 7 |
chr1_+_132007606 | 1.36 |
ENSMUST00000086556.5
|
Elk4
|
ELK4, member of ETS oncogene family |
chr8_-_123158268 | 1.36 |
ENSMUST00000000755.7
|
Sult5a1
|
sulfotransferase family 5A, member 1 |
chr13_-_107890059 | 1.33 |
ENSMUST00000105097.2
|
Zswim6
|
zinc finger SWIM-type containing 6 |
chr4_+_138454305 | 1.33 |
ENSMUST00000050918.3
|
Camk2n1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr2_+_27677234 | 1.33 |
ENSMUST00000166775.1
|
Rxra
|
retinoid X receptor alpha |
chr4_+_47353283 | 1.33 |
ENSMUST00000044234.7
|
Tgfbr1
|
transforming growth factor, beta receptor I |
chr7_-_137314394 | 1.32 |
ENSMUST00000168203.1
ENSMUST00000106118.2 ENSMUST00000169486.2 ENSMUST00000033378.5 |
Ebf3
|
early B cell factor 3 |
chr17_-_31637135 | 1.32 |
ENSMUST00000118504.1
ENSMUST00000078509.5 ENSMUST00000067801.6 |
Cbs
|
cystathionine beta-synthase |
chr11_+_84179792 | 1.31 |
ENSMUST00000137500.2
ENSMUST00000130012.2 |
Acaca
|
acetyl-Coenzyme A carboxylase alpha |
chr1_+_16105774 | 1.31 |
ENSMUST00000027053.7
|
Rdh10
|
retinol dehydrogenase 10 (all-trans) |
chr9_+_46012822 | 1.31 |
ENSMUST00000120463.2
ENSMUST00000120247.1 |
Sik3
|
SIK family kinase 3 |
chr18_+_24205937 | 1.31 |
ENSMUST00000164998.1
|
Galnt1
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 1 |
chrX_-_162643575 | 1.30 |
ENSMUST00000101102.1
|
Reps2
|
RALBP1 associated Eps domain containing protein 2 |
chr5_+_33721724 | 1.30 |
ENSMUST00000067150.7
ENSMUST00000169212.2 ENSMUST00000114411.2 ENSMUST00000164207.3 |
Fgfr3
|
fibroblast growth factor receptor 3 |
chr10_-_95415484 | 1.29 |
ENSMUST00000172070.1
ENSMUST00000150432.1 |
Socs2
|
suppressor of cytokine signaling 2 |
chr8_+_111094630 | 1.29 |
ENSMUST00000135302.1
ENSMUST00000039333.3 |
Pdpr
|
pyruvate dehydrogenase phosphatase regulatory subunit |
chr18_+_5593566 | 1.29 |
ENSMUST00000160910.1
|
Zeb1
|
zinc finger E-box binding homeobox 1 |
chr1_+_33908172 | 1.28 |
ENSMUST00000182513.1
ENSMUST00000183034.1 |
Dst
|
dystonin |
chr2_+_52857844 | 1.28 |
ENSMUST00000090952.4
ENSMUST00000049483.6 ENSMUST00000050719.6 |
Fmnl2
|
formin-like 2 |
chr7_+_45705088 | 1.27 |
ENSMUST00000080885.3
|
Dbp
|
D site albumin promoter binding protein |
chr3_-_122619442 | 1.27 |
ENSMUST00000162947.1
|
Fnbp1l
|
formin binding protein 1-like |
chr10_-_127620960 | 1.27 |
ENSMUST00000121829.1
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr10_-_127620922 | 1.27 |
ENSMUST00000118455.1
|
Lrp1
|
low density lipoprotein receptor-related protein 1 |
chr18_-_3337539 | 1.27 |
ENSMUST00000142690.1
ENSMUST00000025069.4 ENSMUST00000082141.5 ENSMUST00000165086.1 ENSMUST00000149803.1 |
Crem
|
cAMP responsive element modulator |
chr3_+_40950631 | 1.27 |
ENSMUST00000048490.6
|
Larp1b
|
La ribonucleoprotein domain family, member 1B |
chr4_+_85205417 | 1.27 |
ENSMUST00000030212.8
ENSMUST00000107189.1 ENSMUST00000107184.1 |
Sh3gl2
|
SH3-domain GRB2-like 2 |
chr17_+_24804312 | 1.27 |
ENSMUST00000024972.5
|
Meiob
|
meiosis specific with OB domains |
chr2_-_168741752 | 1.26 |
ENSMUST00000029060.4
|
Atp9a
|
ATPase, class II, type 9A |
chrX_+_161717498 | 1.26 |
ENSMUST00000061514.7
|
Rai2
|
retinoic acid induced 2 |
chr15_+_90224293 | 1.25 |
ENSMUST00000100309.1
|
Alg10b
|
asparagine-linked glycosylation 10B (alpha-1,2-glucosyltransferase) |
chr11_-_106612928 | 1.25 |
ENSMUST00000042780.7
|
Tex2
|
testis expressed gene 2 |
chr12_+_21111720 | 1.24 |
ENSMUST00000064595.8
ENSMUST00000101562.4 ENSMUST00000090834.6 |
Asap2
|
ArfGAP with SH3 domain, ankyrin repeat and PH domain 2 |
chr15_+_7129557 | 1.24 |
ENSMUST00000067190.5
ENSMUST00000164529.1 |
Lifr
|
leukemia inhibitory factor receptor |
chr19_-_44069690 | 1.24 |
ENSMUST00000169092.1
|
Erlin1
|
ER lipid raft associated 1 |
chr16_+_31664130 | 1.23 |
ENSMUST00000023454.5
|
Dlg1
|
discs, large homolog 1 (Drosophila) |
chr3_+_107631322 | 1.23 |
ENSMUST00000106703.1
|
Gm10961
|
predicted gene 10961 |
chr2_-_25493905 | 1.23 |
ENSMUST00000028312.6
|
Lcn12
|
lipocalin 12 |
chr15_+_57694651 | 1.22 |
ENSMUST00000096430.4
|
Zhx2
|
zinc fingers and homeoboxes 2 |
chr4_+_11704439 | 1.22 |
ENSMUST00000108304.2
|
Gem
|
GTP binding protein (gene overexpressed in skeletal muscle) |
chr16_-_46496772 | 1.22 |
ENSMUST00000149901.1
ENSMUST00000096052.2 |
Pvrl3
|
poliovirus receptor-related 3 |
chr16_-_24393588 | 1.21 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr18_+_74442500 | 1.21 |
ENSMUST00000074157.6
|
Myo5b
|
myosin VB |
chr10_-_81427114 | 1.20 |
ENSMUST00000078185.7
ENSMUST00000020461.8 ENSMUST00000105321.3 |
Nfic
|
nuclear factor I/C |
chr16_-_34573526 | 1.20 |
ENSMUST00000114961.1
|
Kalrn
|
kalirin, RhoGEF kinase |
chr5_-_110286159 | 1.20 |
ENSMUST00000031472.5
|
Pxmp2
|
peroxisomal membrane protein 2 |
chr7_-_110614761 | 1.19 |
ENSMUST00000166020.1
ENSMUST00000171218.1 ENSMUST00000033058.7 ENSMUST00000164759.1 |
Sbf2
|
SET binding factor 2 |
chr8_+_11728105 | 1.19 |
ENSMUST00000110909.2
ENSMUST00000033908.6 |
Arhgef7
|
Rho guanine nucleotide exchange factor (GEF7) |
chr5_-_65697856 | 1.19 |
ENSMUST00000031104.6
|
Pds5a
|
PDS5, regulator of cohesion maintenance, homolog A (S. cerevisiae) |
chr4_-_108217897 | 1.19 |
ENSMUST00000106690.1
ENSMUST00000043793.6 |
Zyg11a
|
zyg-11 family member A, cell cycle regulator |
chr11_-_20112876 | 1.18 |
ENSMUST00000000137.7
|
Actr2
|
ARP2 actin-related protein 2 |
chr14_-_34502522 | 1.18 |
ENSMUST00000171551.1
|
Bmpr1a
|
bone morphogenetic protein receptor, type 1A |
chr11_+_97799772 | 1.18 |
ENSMUST00000129558.1
|
Lasp1
|
LIM and SH3 protein 1 |
chr1_+_87327008 | 1.18 |
ENSMUST00000172794.1
ENSMUST00000164992.2 |
Gigyf2
|
GRB10 interacting GYF protein 2 |
chr15_-_76195710 | 1.18 |
ENSMUST00000023226.6
|
Plec
|
plectin |
chrX_+_161717055 | 1.17 |
ENSMUST00000112338.1
|
Rai2
|
retinoic acid induced 2 |
chr10_-_31609184 | 1.17 |
ENSMUST00000081989.6
|
Rnf217
|
ring finger protein 217 |
chr1_+_63445842 | 1.17 |
ENSMUST00000087374.3
ENSMUST00000114107.1 ENSMUST00000182642.1 |
Adam23
|
a disintegrin and metallopeptidase domain 23 |
chr9_-_105495037 | 1.17 |
ENSMUST00000176190.1
ENSMUST00000163879.2 ENSMUST00000112558.2 ENSMUST00000176390.1 |
Atp2c1
|
ATPase, Ca++-sequestering |
chr7_+_24611314 | 1.16 |
ENSMUST00000073325.5
|
Phldb3
|
pleckstrin homology-like domain, family B, member 3 |
chr19_-_44069736 | 1.16 |
ENSMUST00000172041.1
ENSMUST00000071698.6 ENSMUST00000112028.3 |
Erlin1
|
ER lipid raft associated 1 |
chr13_-_32802849 | 1.16 |
ENSMUST00000057911.1
|
D930007J09Rik
|
RIKEN cDNA D930007J09 gene |
chr19_-_44069526 | 1.16 |
ENSMUST00000170801.1
|
Erlin1
|
ER lipid raft associated 1 |
chr5_-_107869153 | 1.15 |
ENSMUST00000128723.1
ENSMUST00000124034.1 |
Evi5
|
ecotropic viral integration site 5 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.2 | 4.6 | GO:1903760 | regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1903760) |
1.1 | 8.0 | GO:0070494 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
1.0 | 2.9 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.8 | 3.3 | GO:0099527 | postsynapse to nucleus signaling pathway(GO:0099527) |
0.8 | 4.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.8 | 3.1 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.8 | 2.4 | GO:0030450 | regulation of complement activation, classical pathway(GO:0030450) |
0.8 | 2.3 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.7 | 0.7 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.7 | 2.2 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.7 | 2.9 | GO:1904412 | regulation of cardiac ventricle development(GO:1904412) |
0.7 | 3.5 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.7 | 2.1 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.7 | 2.7 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.7 | 2.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.7 | 4.0 | GO:0003383 | apical constriction(GO:0003383) |
0.7 | 3.3 | GO:0009414 | response to water deprivation(GO:0009414) |
0.6 | 1.9 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.6 | 1.9 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) coronal suture morphogenesis(GO:0060365) |
0.6 | 1.8 | GO:0035621 | ER to Golgi ceramide transport(GO:0035621) |
0.6 | 4.0 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.6 | 2.8 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.5 | 1.6 | GO:1905223 | epicardium morphogenesis(GO:1905223) |
0.5 | 2.1 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.5 | 3.6 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.5 | 2.5 | GO:0031438 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.5 | 1.5 | GO:0061181 | regulation of chondrocyte development(GO:0061181) |
0.5 | 1.0 | GO:0055005 | ventricular cardiac myofibril assembly(GO:0055005) |
0.5 | 1.4 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.5 | 1.9 | GO:0032468 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
0.5 | 1.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.5 | 1.8 | GO:0042851 | L-alanine metabolic process(GO:0042851) |
0.5 | 3.2 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.4 | 11.6 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 1.3 | GO:1900477 | negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter(GO:1900477) |
0.4 | 2.2 | GO:0045994 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) |
0.4 | 7.6 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.4 | 1.7 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.4 | 1.7 | GO:0071449 | cellular response to lipid hydroperoxide(GO:0071449) |
0.4 | 0.4 | GO:0060168 | positive regulation of adenosine receptor signaling pathway(GO:0060168) |
0.4 | 1.6 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.4 | 3.6 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.4 | 1.2 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
0.4 | 2.3 | GO:1904936 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.4 | 2.7 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
0.4 | 1.1 | GO:0071579 | regulation of zinc ion transport(GO:0071579) |
0.4 | 2.2 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.4 | 1.1 | GO:0042560 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.4 | 1.1 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 1.0 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 1.0 | GO:0060574 | intestinal epithelial cell maturation(GO:0060574) |
0.3 | 1.0 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.3 | 1.4 | GO:0045358 | negative regulation of interferon-beta biosynthetic process(GO:0045358) |
0.3 | 1.0 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.3 | 2.0 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.3 | 3.4 | GO:0046959 | habituation(GO:0046959) |
0.3 | 2.0 | GO:0032439 | endosome localization(GO:0032439) |
0.3 | 1.0 | GO:0001982 | baroreceptor response to decreased systemic arterial blood pressure(GO:0001982) |
0.3 | 1.0 | GO:0006772 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.3 | 1.0 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
0.3 | 1.3 | GO:0044268 | multicellular organismal protein metabolic process(GO:0044268) |
0.3 | 2.9 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.3 | 0.9 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.3 | 2.8 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.3 | 1.2 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
0.3 | 0.9 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.3 | 0.9 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.3 | 3.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.3 | 0.9 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.3 | 2.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 3.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 1.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.3 | 0.8 | GO:0045204 | MAPK export from nucleus(GO:0045204) |
0.3 | 1.1 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.3 | 1.1 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.3 | 0.8 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.3 | 1.6 | GO:0060431 | primary lung bud formation(GO:0060431) |
0.3 | 0.8 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
0.3 | 0.8 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.3 | 1.0 | GO:0097494 | regulation of vesicle size(GO:0097494) |
0.3 | 0.5 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.3 | 1.5 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.3 | 1.5 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.3 | 1.8 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
0.3 | 0.8 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
0.3 | 0.3 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.2 | 0.7 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.2 | 0.7 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
0.2 | 1.2 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 0.7 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 1.0 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.2 | 0.7 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.2 | 1.5 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.5 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 0.5 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.2 | 0.7 | GO:1902022 | L-lysine transport(GO:1902022) |
0.2 | 0.7 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.2 | 1.9 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.2 | 1.1 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 3.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.2 | 0.7 | GO:0046168 | glycerol-3-phosphate catabolic process(GO:0046168) |
0.2 | 0.2 | GO:1901630 | negative regulation of presynaptic membrane organization(GO:1901630) |
0.2 | 0.9 | GO:0060128 | corticotropin hormone secreting cell differentiation(GO:0060128) |
0.2 | 1.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 0.9 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) condensed mesenchymal cell proliferation(GO:0072137) |
0.2 | 1.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.2 | 0.6 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.2 | 0.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 1.9 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.8 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.2 | 2.7 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.2 | 2.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.2 | 0.6 | GO:0061076 | camera-type eye photoreceptor cell fate commitment(GO:0060220) negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.2 | 0.2 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 3.0 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.2 | 1.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.2 | 0.4 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
0.2 | 2.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 1.9 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
0.2 | 0.6 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.2 | 1.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.2 | 1.1 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.2 | 0.7 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.2 | 0.5 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.2 | 0.9 | GO:0097118 | neuroligin clustering involved in postsynaptic membrane assembly(GO:0097118) |
0.2 | 0.5 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.2 | 0.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.2 | 0.9 | GO:0060454 | positive regulation of gastric acid secretion(GO:0060454) |
0.2 | 0.5 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.2 | 0.7 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.2 | 0.5 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) malonyl-CoA metabolic process(GO:2001293) |
0.2 | 0.7 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.2 | 0.7 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 1.2 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
0.2 | 1.5 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 2.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.2 | 2.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.8 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.2 | 3.0 | GO:0006491 | N-glycan processing(GO:0006491) |
0.2 | 0.2 | GO:0030202 | heparin metabolic process(GO:0030202) |
0.2 | 1.1 | GO:0090032 | negative regulation of steroid hormone biosynthetic process(GO:0090032) |
0.2 | 1.3 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.6 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 1.1 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.2 | 0.6 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.9 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.2 | 0.5 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.1 | 0.6 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.1 | 1.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.1 | 0.4 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 4.0 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 1.6 | GO:2000582 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 0.4 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.9 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.6 | GO:0021564 | vagus nerve development(GO:0021564) |
0.1 | 0.9 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 4.8 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.1 | 0.4 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
0.1 | 1.3 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.1 | 0.3 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.7 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.1 | 0.3 | GO:0003180 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
0.1 | 0.4 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.1 | 0.6 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.1 | 0.7 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.4 | GO:1990927 | calcium ion regulated lysosome exocytosis(GO:1990927) |
0.1 | 0.8 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.1 | 0.8 | GO:0035878 | nail development(GO:0035878) |
0.1 | 1.2 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.1 | 0.3 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.1 | 0.7 | GO:0008300 | isoprenoid catabolic process(GO:0008300) |
0.1 | 5.9 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 0.1 | GO:0032242 | regulation of nucleoside transport(GO:0032242) |
0.1 | 2.3 | GO:0042448 | progesterone metabolic process(GO:0042448) |
0.1 | 0.4 | GO:0071799 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.1 | 0.6 | GO:2000664 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.3 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
0.1 | 0.9 | GO:0060903 | positive regulation of meiosis I(GO:0060903) |
0.1 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.1 | 1.1 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.5 | GO:0008078 | mesodermal cell migration(GO:0008078) |
0.1 | 0.4 | GO:0015881 | creatine transport(GO:0015881) |
0.1 | 0.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 1.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.1 | 2.5 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.7 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.1 | 0.6 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.1 | 0.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 1.3 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.1 | 0.9 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 1.0 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.1 | 1.0 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 0.3 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.1 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 1.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.1 | 3.9 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.6 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.4 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 1.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.1 | 1.0 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.1 | 0.3 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.1 | 1.0 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.1 | 1.6 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.1 | 1.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.8 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
0.1 | 0.4 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 0.6 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
0.1 | 0.4 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.1 | 5.6 | GO:1902653 | cholesterol biosynthetic process(GO:0006695) secondary alcohol biosynthetic process(GO:1902653) |
0.1 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.1 | 0.7 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 2.8 | GO:0033622 | integrin activation(GO:0033622) |
0.1 | 0.4 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.4 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
0.1 | 1.7 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.1 | 0.6 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.5 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
0.1 | 0.2 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
0.1 | 1.3 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.1 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.8 | GO:0060355 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.9 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 2.5 | GO:0061157 | mRNA destabilization(GO:0061157) |
0.1 | 0.5 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.1 | 0.8 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.1 | 0.9 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 1.1 | GO:1901898 | negative regulation of relaxation of cardiac muscle(GO:1901898) |
0.1 | 2.6 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.1 | 0.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.1 | 1.0 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.1 | 1.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 0.4 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 1.0 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.4 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.2 | GO:0036394 | amylase secretion(GO:0036394) |
0.1 | 0.9 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 1.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.1 | 1.1 | GO:0055059 | asymmetric neuroblast division(GO:0055059) |
0.1 | 2.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
0.1 | 0.1 | GO:0021683 | cerebellar granular layer morphogenesis(GO:0021683) |
0.1 | 0.9 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.1 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.1 | 0.4 | GO:0044857 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.1 | 0.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 1.2 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 1.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 0.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.6 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
0.1 | 0.2 | GO:0098885 | actin filament bundle distribution(GO:0070650) modification of postsynaptic actin cytoskeleton(GO:0098885) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.9 | GO:0070842 | aggresome assembly(GO:0070842) |
0.1 | 0.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.1 | 0.2 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.1 | 0.6 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 0.1 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 2.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 1.0 | GO:0046519 | sphingoid metabolic process(GO:0046519) |
0.1 | 0.1 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
0.1 | 0.3 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.8 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.1 | 0.3 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) negative regulation of defense response to virus by host(GO:0050689) positive regulation of macromitophagy(GO:1901526) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.1 | 0.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 1.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 0.8 | GO:0019985 | translesion synthesis(GO:0019985) |
0.1 | 0.8 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.1 | 0.3 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.7 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.1 | 1.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.1 | 0.1 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.1 | 0.6 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.1 | 5.0 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.1 | 0.4 | GO:0006983 | ER overload response(GO:0006983) |
0.1 | 0.4 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.4 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.8 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.2 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.1 | 0.5 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.1 | 0.7 | GO:0061088 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.1 | 0.8 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.2 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
0.1 | 4.8 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 2.4 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 4.2 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.6 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.1 | 0.6 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.1 | 0.3 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
0.1 | 0.9 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 1.0 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 0.6 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.6 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.1 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.1 | 0.2 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.1 | 0.3 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.6 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.1 | 0.4 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.7 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.1 | 0.6 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.2 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 1.0 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.1 | 0.4 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.2 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.6 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
0.1 | 0.4 | GO:0070166 | enamel mineralization(GO:0070166) |
0.1 | 0.2 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.1 | 0.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.1 | 0.9 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.0 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.0 | 0.2 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.0 | 0.7 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.0 | 0.8 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.0 | 0.5 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.2 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.0 | 0.3 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.2 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.0 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.0 | 0.2 | GO:0030321 | transepithelial chloride transport(GO:0030321) transepithelial ammonium transport(GO:0070634) |
0.0 | 0.7 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.3 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.7 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.0 | 0.6 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.0 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.4 | GO:0015879 | carnitine transport(GO:0015879) |
0.0 | 0.4 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.0 | 0.2 | GO:0010989 | negative regulation of low-density lipoprotein particle clearance(GO:0010989) |
0.0 | 0.7 | GO:0045723 | positive regulation of fatty acid biosynthetic process(GO:0045723) |
0.0 | 0.5 | GO:0061377 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
0.0 | 0.8 | GO:0043306 | positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
0.0 | 0.5 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.0 | 0.5 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.2 | GO:0097421 | liver regeneration(GO:0097421) |
0.0 | 1.1 | GO:0006084 | acetyl-CoA metabolic process(GO:0006084) |
0.0 | 0.2 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.0 | 0.4 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.0 | 0.5 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.0 | 0.2 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.0 | 0.9 | GO:0001702 | gastrulation with mouth forming second(GO:0001702) |
0.0 | 2.0 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.8 | GO:0098596 | vocal learning(GO:0042297) imitative learning(GO:0098596) learned vocalization behavior or vocal learning(GO:0098598) |
0.0 | 0.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.4 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.0 | 0.5 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.0 | 0.2 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 1.4 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
0.0 | 0.2 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.0 | 0.2 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.1 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.0 | 1.1 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.4 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.0 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.0 | 0.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
0.0 | 0.1 | GO:0002030 | inhibitory G-protein coupled receptor phosphorylation(GO:0002030) activation of meiosis involved in egg activation(GO:0060466) activation of meiosis(GO:0090427) |
0.0 | 0.5 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
0.0 | 0.4 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.3 | GO:0033216 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.0 | 0.3 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.0 | 0.3 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.2 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.5 | GO:0072189 | ureter development(GO:0072189) |
0.0 | 0.5 | GO:0033273 | response to vitamin(GO:0033273) |
0.0 | 0.4 | GO:0030903 | notochord development(GO:0030903) |
0.0 | 0.5 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.0 | 0.4 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.3 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.4 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.9 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.6 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.0 | 0.6 | GO:0009311 | oligosaccharide metabolic process(GO:0009311) |
0.0 | 0.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.5 | GO:0014823 | response to activity(GO:0014823) |
0.0 | 0.4 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.1 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) |
0.0 | 0.1 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.0 | 0.5 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 1.0 | GO:0032835 | glomerulus development(GO:0032835) |
0.0 | 0.4 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.4 | GO:0090308 | regulation of methylation-dependent chromatin silencing(GO:0090308) |
0.0 | 0.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.0 | 1.2 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.3 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.0 | 0.2 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.4 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.0 | 0.1 | GO:0038163 | endomitotic cell cycle(GO:0007113) thrombopoietin-mediated signaling pathway(GO:0038163) positive regulation of male germ cell proliferation(GO:2000256) |
0.0 | 0.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.2 | GO:0060179 | male mating behavior(GO:0060179) |
0.0 | 0.2 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 1.2 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.6 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.0 | 0.2 | GO:0090153 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
0.0 | 0.2 | GO:0014004 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.0 | 0.1 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 0.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.2 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
0.0 | 0.2 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.0 | 0.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.1 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.0 | 0.3 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.0 | 0.4 | GO:0046130 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.0 | 0.1 | GO:0090383 | phagosome acidification(GO:0090383) |
0.0 | 0.3 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.5 | GO:0036503 | ERAD pathway(GO:0036503) |
0.0 | 0.5 | GO:0045738 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.0 | 0.7 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.0 | 0.5 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.4 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.0 | 0.5 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 1.6 | GO:0022900 | electron transport chain(GO:0022900) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.2 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.2 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.3 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.9 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.0 | 0.3 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.3 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 0.3 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.0 | 0.7 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.0 | 0.1 | GO:1990253 | cellular response to leucine starvation(GO:1990253) |
0.0 | 0.6 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.3 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.1 | GO:0097090 | presynaptic membrane organization(GO:0097090) regulation of presynaptic membrane organization(GO:1901629) |
0.0 | 0.5 | GO:0006110 | regulation of glycolytic process(GO:0006110) |
0.0 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.8 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.0 | 0.2 | GO:1903818 | positive regulation of voltage-gated potassium channel activity(GO:1903818) |
0.0 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 1.0 | GO:0050688 | regulation of defense response to virus(GO:0050688) |
0.0 | 0.2 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
0.0 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.0 | 0.3 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 1.8 | GO:0035023 | regulation of Rho protein signal transduction(GO:0035023) |
0.0 | 0.5 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.0 | 0.5 | GO:0031018 | endocrine pancreas development(GO:0031018) |
0.0 | 0.3 | GO:1903206 | negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
0.0 | 0.2 | GO:0021794 | thalamus development(GO:0021794) |
0.0 | 0.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.0 | 0.4 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.5 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
0.0 | 0.1 | GO:0015676 | vanadium ion transport(GO:0015676) plasma membrane copper ion transport(GO:0015679) lead ion transport(GO:0015692) copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.1 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.0 | 0.2 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.0 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.0 | 0.0 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.2 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.0 | 0.3 | GO:0007584 | response to nutrient(GO:0007584) |
0.0 | 0.1 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
0.0 | 0.1 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
0.0 | 0.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.0 | 1.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.0 | 0.2 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.1 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.0 | 0.2 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.0 | 0.1 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.0 | 0.0 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.4 | GO:0042475 | odontogenesis of dentin-containing tooth(GO:0042475) |
0.0 | 0.6 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.0 | 0.1 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.0 | 0.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.0 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.0 | 0.0 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.3 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.1 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.0 | GO:0040030 | regulation of molecular function, epigenetic(GO:0040030) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 4.9 | GO:0038039 | G-protein coupled receptor heterodimeric complex(GO:0038039) |
0.7 | 4.6 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.4 | 3.9 | GO:0043219 | lateral loop(GO:0043219) |
0.4 | 2.5 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.3 | 5.5 | GO:0070852 | cell body fiber(GO:0070852) |
0.3 | 1.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.3 | 1.0 | GO:0098855 | HCN channel complex(GO:0098855) |
0.3 | 2.3 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.3 | 5.5 | GO:0030056 | hemidesmosome(GO:0030056) |
0.3 | 1.1 | GO:0017133 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.3 | 0.8 | GO:0097232 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.3 | 1.0 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.2 | 1.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.2 | 1.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.2 | 1.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 2.5 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 2.4 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 3.1 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.2 | 3.1 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 0.9 | GO:0030891 | VCB complex(GO:0030891) |
0.2 | 1.9 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.2 | 0.7 | GO:0099569 | presynaptic cytoskeleton(GO:0099569) |
0.2 | 2.8 | GO:1990635 | proximal dendrite(GO:1990635) |
0.2 | 3.2 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 0.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.2 | 1.0 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.2 | 0.6 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.2 | 0.6 | GO:0044308 | axonal spine(GO:0044308) |
0.2 | 1.8 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 3.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 10.8 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.1 | 0.7 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 2.4 | GO:0033391 | chromatoid body(GO:0033391) |
0.1 | 0.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.1 | 1.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.9 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.8 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.6 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.1 | 1.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 0.8 | GO:0005827 | polar microtubule(GO:0005827) |
0.1 | 0.3 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
0.1 | 1.4 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.1 | 1.5 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 0.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 1.4 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.1 | 4.3 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.3 | GO:0032010 | phagolysosome(GO:0032010) |
0.1 | 1.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.1 | 0.8 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.7 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 2.2 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.9 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.8 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 0.5 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.1 | 1.8 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 2.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.9 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.9 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.1 | 0.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.1 | 0.4 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.1 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.5 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.1 | 0.8 | GO:0016589 | NURF complex(GO:0016589) |
0.1 | 5.9 | GO:0005776 | autophagosome(GO:0005776) |
0.1 | 1.0 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 1.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.7 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.1 | 3.0 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.1 | 0.8 | GO:0031209 | SCAR complex(GO:0031209) |
0.1 | 0.3 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
0.1 | 0.2 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 1.7 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.1 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.2 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.3 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 6.1 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 0.9 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 3.8 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.0 | 1.0 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 0.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.3 | GO:0030870 | Mre11 complex(GO:0030870) |
0.0 | 0.4 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.0 | 2.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 0.1 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
0.0 | 1.6 | GO:0005876 | spindle microtubule(GO:0005876) |
0.0 | 1.1 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.7 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.4 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 1.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 1.9 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.0 | 2.5 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.2 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.0 | 3.1 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.8 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.5 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.3 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.4 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.0 | 0.4 | GO:0030126 | COPI vesicle coat(GO:0030126) COPI-coated vesicle membrane(GO:0030663) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 1.0 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 0.8 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.4 | GO:0033268 | node of Ranvier(GO:0033268) |
0.0 | 1.3 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 8.8 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.2 | GO:0071565 | nBAF complex(GO:0071565) |
0.0 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.0 | 1.5 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
0.0 | 0.1 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.2 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.0 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.4 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.4 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 2.3 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.0 | 0.2 | GO:0001652 | granular component(GO:0001652) |
0.0 | 1.4 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.1 | GO:0071953 | elastic fiber(GO:0071953) |
0.0 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 1.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 1.2 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 0.1 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.0 | 2.1 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.4 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.0 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.9 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.0 | 0.7 | GO:0044295 | axonal growth cone(GO:0044295) |
0.0 | 0.1 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 0.2 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0031313 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
0.0 | 1.2 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.0 | 0.1 | GO:0097342 | death-inducing signaling complex(GO:0031264) ripoptosome(GO:0097342) |
0.0 | 1.2 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0070826 | paraferritin complex(GO:0070826) |
0.0 | 0.2 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 2.2 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 0.1 | GO:0032433 | filopodium tip(GO:0032433) |
0.0 | 5.4 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.0 | 0.1 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.2 | GO:0000124 | SAGA complex(GO:0000124) |
0.0 | 0.5 | GO:0015030 | Cajal body(GO:0015030) |
0.0 | 0.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.6 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.0 | GO:0071439 | clathrin complex(GO:0071439) |
0.0 | 2.0 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.0 | 0.1 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.0 | 4.3 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 3.2 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.3 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 0.0 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 8.0 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
1.0 | 3.1 | GO:0016964 | alpha-2 macroglobulin receptor activity(GO:0016964) |
1.0 | 4.8 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
1.0 | 2.9 | GO:0098809 | nitrite reductase activity(GO:0098809) |
0.8 | 4.9 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.8 | 4.6 | GO:0097016 | L27 domain binding(GO:0097016) |
0.7 | 2.0 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.7 | 2.7 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.6 | 0.6 | GO:0019981 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.6 | 1.9 | GO:0015229 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.6 | 2.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.6 | 4.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.5 | 2.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.5 | 2.1 | GO:0003865 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.5 | 4.2 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
0.5 | 1.5 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
0.5 | 2.5 | GO:2001070 | starch binding(GO:2001070) |
0.5 | 1.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.5 | 1.9 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
0.4 | 3.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 2.6 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.4 | 2.5 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.4 | 1.2 | GO:0004923 | leukemia inhibitory factor receptor activity(GO:0004923) |
0.4 | 1.9 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.4 | 1.1 | GO:0031751 | D4 dopamine receptor binding(GO:0031751) |
0.4 | 1.1 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
0.4 | 1.8 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.4 | 3.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.3 | 1.7 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 1.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 1.3 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.3 | 1.3 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.3 | 1.9 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.3 | 0.9 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
0.3 | 1.8 | GO:0097001 | ceramide binding(GO:0097001) |
0.3 | 0.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.3 | 0.9 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
0.3 | 6.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.3 | 0.9 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
0.3 | 1.7 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.3 | 0.9 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.3 | 1.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.3 | 2.9 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 1.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.3 | 1.1 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.3 | 1.1 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.3 | 3.0 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.3 | 2.9 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.3 | 0.8 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.3 | 4.2 | GO:0030957 | Tat protein binding(GO:0030957) |
0.3 | 1.0 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.3 | 1.3 | GO:0004661 | protein geranylgeranyltransferase activity(GO:0004661) |
0.3 | 5.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.2 | 1.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.2 | 1.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.2 | 1.4 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.2 | 0.7 | GO:0047522 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.2 | 3.6 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.2 | 0.9 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.2 | 5.4 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.2 | 0.7 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.2 | 1.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.2 | 1.1 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.2 | 1.1 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
0.2 | 1.1 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.2 | 2.8 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.2 | 0.8 | GO:0008802 | betaine-aldehyde dehydrogenase activity(GO:0008802) |
0.2 | 0.2 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.2 | 1.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.2 | 1.0 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.2 | 1.4 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.2 | 0.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 8.5 | GO:0003785 | actin monomer binding(GO:0003785) |
0.2 | 1.0 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.2 | 1.3 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.2 | 0.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
0.2 | 0.7 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.2 | 0.9 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.2 | 1.7 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 1.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.2 | 1.0 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 1.8 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 1.6 | GO:1990239 | steroid hormone binding(GO:1990239) |
0.2 | 0.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.2 | 1.0 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
0.2 | 0.5 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.2 | 0.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.2 | 0.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.1 | 0.7 | GO:0070012 | oligopeptidase activity(GO:0070012) |
0.1 | 0.7 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 2.3 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.1 | 0.6 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 2.0 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 0.4 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.7 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) L-lysine transmembrane transporter activity(GO:0015189) |
0.1 | 3.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.7 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.1 | 0.6 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.1 | 0.7 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.1 | 3.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.0 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.4 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.1 | 4.9 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 1.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 2.4 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.1 | 1.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.1 | 0.4 | GO:0005308 | creatine transmembrane transporter activity(GO:0005308) |
0.1 | 7.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.1 | 3.7 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.1 | 0.7 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
0.1 | 2.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.1 | 1.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.1 | 6.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 2.0 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 0.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.1 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 0.4 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.1 | 0.4 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 1.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.1 | 0.7 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.1 | 1.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 0.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.1 | 0.4 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
0.1 | 3.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.1 | 0.8 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.1 | 0.5 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 1.6 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.3 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.6 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.1 | 0.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 0.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.1 | 0.6 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.4 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 0.3 | GO:0030984 | kininogen binding(GO:0030984) |
0.1 | 1.5 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 1.7 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 3.6 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.1 | 2.7 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.4 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.1 | 1.2 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.9 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 0.5 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 0.4 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.7 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.1 | 1.0 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 3.3 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.1 | 1.1 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.1 | 0.4 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.1 | 4.1 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.1 | 1.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.5 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.1 | 1.8 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 1.0 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.1 | 1.0 | GO:0015250 | water channel activity(GO:0015250) |
0.1 | 0.5 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 2.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 1.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.5 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.1 | 0.2 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.1 | 3.6 | GO:0015485 | cholesterol binding(GO:0015485) |
0.1 | 0.5 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.1 | 1.7 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 1.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0002135 | CTP binding(GO:0002135) |
0.1 | 1.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.1 | 0.2 | GO:0005333 | norepinephrine transmembrane transporter activity(GO:0005333) |
0.1 | 0.2 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.1 | 0.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.1 | 3.5 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.1 | 0.7 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 4.7 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.7 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.2 | GO:0047237 | glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047237) |
0.0 | 1.1 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.2 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.6 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.0 | 0.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.1 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.0 | 2.3 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.0 | 0.5 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 1.3 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.0 | 0.2 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.0 | 1.1 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 1.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.0 | 0.3 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.0 | 0.4 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.0 | 0.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.0 | 0.3 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.8 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.0 | 2.0 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 0.6 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.0 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.0 | 0.6 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.0 | 0.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 3.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 1.0 | GO:0001848 | complement binding(GO:0001848) |
0.0 | 0.1 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) alpha2-adrenergic receptor activity(GO:0004938) |
0.0 | 4.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.4 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 1.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.0 | 0.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.3 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.2 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
0.0 | 2.2 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.2 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.0 | 0.6 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.2 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.0 | 0.1 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
0.0 | 1.5 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.6 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.7 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
0.0 | 1.5 | GO:0008081 | phosphoric diester hydrolase activity(GO:0008081) |
0.0 | 0.1 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.0 | 0.3 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.0 | 0.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.4 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.0 | GO:0001132 | RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly(GO:0001129) RNA polymerase II transcription factor activity, TBP-class protein binding(GO:0001132) |
0.0 | 0.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.0 | 0.7 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
0.0 | 1.1 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.1 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.0 | 0.4 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 2.3 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 0.2 | GO:0016679 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.2 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.2 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.0 | 0.9 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.6 | GO:0042165 | neurotransmitter binding(GO:0042165) |
0.0 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 1.4 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.1 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.0 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 1.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.2 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.3 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 2.6 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.0 | 0.4 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.0 | 0.0 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.0 | 0.4 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.2 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.1 | GO:0031800 | type 3 metabotropic glutamate receptor binding(GO:0031800) |
0.0 | 0.1 | GO:0015639 | cadmium ion transmembrane transporter activity(GO:0015086) lead ion transmembrane transporter activity(GO:0015094) vanadium ion transmembrane transporter activity(GO:0015100) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.3 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.0 | 0.1 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 1.3 | GO:0008238 | exopeptidase activity(GO:0008238) |
0.0 | 0.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.0 | 0.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 0.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.2 | GO:0005123 | death receptor binding(GO:0005123) |
0.0 | 0.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.1 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.0 | 0.3 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.0 | 0.0 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.5 | PID ALK2 PATHWAY | ALK2 signaling events |
0.3 | 12.1 | PID ARF6 PATHWAY | Arf6 signaling events |
0.1 | 4.9 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 0.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 7.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 0.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 4.6 | PID FGF PATHWAY | FGF signaling pathway |
0.1 | 2.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 3.7 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 4.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.4 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 4.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 3.3 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 2.2 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 2.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 0.9 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 0.4 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.1 | 2.5 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 5.7 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 1.0 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.1 | 1.0 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 3.0 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.3 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 0.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.6 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.1 | 1.7 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 2.1 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 1.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 1.5 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.0 | 2.4 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 2.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 2.3 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 0.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.0 | 0.5 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 0.9 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 2.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.8 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 1.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.8 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.4 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 1.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.7 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.5 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.2 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 5.8 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.0 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 1.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 4.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 1.6 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 0.6 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 0.4 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.0 | 3.1 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.4 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.3 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 0.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.3 | 1.3 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.4 | 11.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.3 | 8.8 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.3 | 0.9 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
0.3 | 10.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.3 | 5.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 4.0 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 0.4 | REACTOME OPIOID SIGNALLING | Genes involved in Opioid Signalling |
0.2 | 2.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.2 | 3.1 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 7.8 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.2 | 3.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.2 | 5.3 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.2 | 2.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.2 | 3.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 3.0 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.2 | 7.1 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 3.6 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 4.8 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 2.2 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 1.5 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 3.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 2.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.1 | 3.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.1 | 1.3 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 1.8 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.1 | 1.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.1 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 0.4 | REACTOME PERK REGULATED GENE EXPRESSION | Genes involved in PERK regulated gene expression |
0.1 | 1.0 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 1.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 2.3 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 2.4 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.0 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.1 | 1.1 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 0.9 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.7 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 1.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 3.8 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.1 | 4.0 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 0.8 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 5.6 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 3.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 0.9 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.1 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.2 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.1 | 0.5 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 0.7 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.1 | 0.9 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 1.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.1 | 0.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.1 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 0.7 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 1.0 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 1.7 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 2.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.5 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.0 | 1.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 0.5 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.0 | 1.5 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 3.0 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.4 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 1.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.6 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.0 | 0.4 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 0.3 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.0 | 0.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 1.2 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 2.3 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.4 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 0.2 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
0.0 | 1.5 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.3 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.0 | 1.3 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
0.0 | 1.2 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.7 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 1.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 1.2 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.0 | 0.5 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.5 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 0.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 1.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.4 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 0.9 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.1 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 0.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.0 | 0.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.0 | 0.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.4 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.0 | 0.4 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |